Featured Research

from universities, journals, and other organizations

New Model To Aid Pancreatic Cancer Research

Date:
January 1, 2007
Source:
Vanderbilt University Medical Center
Summary:
Vanderbilt-Ingram Cancer Center researchers have developed a new animal model for pancreatic cancer that exhibits a high degree of similarity to human tumors.

Vanderbilt-Ingram Cancer Center researchers have developed a new animal model for pancreatic cancer that exhibits a high degree of similarity to human tumors.

Results from the genetically-engineered mice, published online Nov. 14 in the journal Genes and Development, suggest that the mice could provide new opportunities to investigate targeted chemotherapeutics and screening methods for one of the most deadly cancers.

With a 5-year survival rate of less than 5 percent, pancreatic cancer is one of the most lethal cancers. "Most cases are diagnosed at a late stage when it is incurable," said Hal Moses, M.D., the Hortense B. Ingram Professor of Molecular Oncology, professor of Cancer Biology and senior author on the study.

If appropriate, surgery is the most successful treatment option. However, surgery is usually unable to help patients with advanced disease, and there is currently no effective chemotherapy regimen.

Developing an animal model of pancreatic cancer is essential to identifying new treatment and screening options, but progress has been slow. The first realistic pancreatic cancer model, reported in 2003, involved a mutation in a single gene, called Kras. A mutation in this gene is among the earliest genetic changes observed in human pancreatic cancers. Yet the model does not mimic human disease closely.

"Kras mutation alone is not a very good model because it mainly gives a precursor condition," said Moses. This precursor condition called PanIN (pancreatic intraepithelial neoplasia) rarely progresses to the tumor type seen in humans, called PDAC (pancreatic ductal adenocarcinoma).

Kras mutation is considered a "tumor-initiating" event, but additional mutations in other genes are probably required for progression to a clinically relevant tumor. For the past few years, researchers have been searching for a combination of genetic mutations that recapitulates human pancreatic cancer in animals.

To hopefully improve upon previous models, Moses and colleagues have combined the Kras mutation with a "knock out" of the type II TGFƒ receptor (TGFBR2), a component of a signaling pathway that inhibits cell growth. Loss of TGFƒ signaling could remove the molecular "checks and balances" on cell growth, allowing unrestrained cell proliferation and tumor formation.

The researchers used a genetic manipulation that allowed them to control these genetic changes in pancreatic cells only. The resulting tumors were localized to the pancreas, with no extraneous tumor formation in other tissues V a problem that has complicated previous models.

"Our model is more aggressive in terms of survival time," said Hideaki Ijichi, M.D., Ph.D., research fellow and lead author on the study. The mice survive approximately two months, reflecting the aggressiveness of human pancreatic tumors.

Also, the microscopic appearance of tumors in the new model more closely resembles that of human tumors.

"Combining the Kras mutation with the TGFBR2 knock-out resulted in 100 percent penetrance in developing tumors that histologically and clinically looks very much like human disease," said Moses.

"A certain percentage (of the previous models) have a sarcomatoid histology, which is very rare in humans," Ijichi said. "Our model has almost no sarcomatoid histology."

Ijichi and Moses are planning to use the new model to test targeted drug therapies and identify possible screening methods that could be used for early detection of pancreatic cancer V something that is sorely lacking for humans.

Progress is indeed picking up in the field. Publishing in the same issue of the journal, a research group from Harvard University reports the development of another pancreatic cancer mouse model. Ronald DePinho, M.D., and colleagues combined the same Kras mutation with a "knockout" of a downstream component of the TGFƒ pathway, called Smad4.

While the Smad4 mutations are more commonly found in humans than mutations in the TGFBR2, the mice developed by DePinho and colleagues did not show the PDAC histology observed in Moses' mice.

Just why a mutation that is more common clinically would induce tumors that are unlike human cancers is unclear, Moses said.

"We really want to know the underlying mechanism of pancreatic carcinogenesis," said Ijichi. And these new animal models now provide researchers with two additional tools with which to investigate this problem.

Other Vanderbilt authors include Anna Chytil, Agnieszka Gorska, Mary Aakre, Yoshio Fujitani, M.D., Ph.D., Shuko Fujitani, M.D., and Christopher V. E. Wright, D. Phil. The research was supported by the National Institutes of Health, the T. J. Martell Foundation and the Uehara Memorial Foundation.


Story Source:

The above story is based on materials provided by Vanderbilt University Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

Vanderbilt University Medical Center. "New Model To Aid Pancreatic Cancer Research." ScienceDaily. ScienceDaily, 1 January 2007. <www.sciencedaily.com/releases/2006/11/061116114236.htm>.
Vanderbilt University Medical Center. (2007, January 1). New Model To Aid Pancreatic Cancer Research. ScienceDaily. Retrieved April 18, 2014 from www.sciencedaily.com/releases/2006/11/061116114236.htm
Vanderbilt University Medical Center. "New Model To Aid Pancreatic Cancer Research." ScienceDaily. www.sciencedaily.com/releases/2006/11/061116114236.htm (accessed April 18, 2014).

Share This



More Health & Medicine News

Friday, April 18, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Scientists Create Stem Cells From Adult Skin Cells

Scientists Create Stem Cells From Adult Skin Cells

Newsy (Apr. 17, 2014) The breakthrough could mean a cure for some serious diseases and even the possibility of human cloning, but it's all still a way off. Video provided by Newsy
Powered by NewsLook.com
Obama: 8 Million Healthcare Signups

Obama: 8 Million Healthcare Signups

AP (Apr. 17, 2014) President Barack Obama gave a briefing Thursday announcing 8 million people have signed up under the Affordable Care Act. He blasted continued Republican efforts to repeal the law. (April 17) Video provided by AP
Powered by NewsLook.com
Is Apathy A Sign Of A Shrinking Brain?

Is Apathy A Sign Of A Shrinking Brain?

Newsy (Apr. 17, 2014) A recent study links apathetic feelings to a smaller brain. Researchers say the results indicate a need for apathy screening for at-risk seniors. Video provided by Newsy
Powered by NewsLook.com
Could Even Casual Marijuana Use Alter Your Brain?

Could Even Casual Marijuana Use Alter Your Brain?

Newsy (Apr. 16, 2014) A new study conducted by researchers at Northwestern and Harvard suggests even casual marijuana use can alter your brain. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins